Apellis Pharmaceuticals Cash from Investing (TTM) Analysis

Apellis Pharmaceuticals Inc (APLS)

47.93 -2.00 (-4.01%) USD | NASDAQ | Apr 25, 16:00

50.06 +2.13 (+4.44%) Pre-Market: 08:47

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	-0.674M
September 30, 2023	123.45M
June 30, 2023	248.28M
March 31, 2023	331.58M
December 31, 2022	59.89M
September 30, 2022	20.74M
June 30, 2022	75.61M
March 31, 2022	122.43M
December 31, 2021	247.62M
September 30, 2021	162.54M
June 30, 2021	181.66M

Date	Value
March 31, 2021	-235.90M
December 31, 2020	-316.99M
September 30, 2020	-317.05M
June 30, 2020	-516.29M
March 31, 2020	-228.67M
December 31, 2019	-1.693M
September 30, 2019	-1.538M
June 30, 2019	-1.067M
March 31, 2019	-0.875M
December 31, 2018	0.00

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-516.29M

Minimum

Jun 2020

331.58M

Maximum

Mar 2023

-2.424M

Average

20.74M

Median

Sep 2022

Cash from Investing (TTM) Benchmarks